COMMUNIQUÉS West-GlobeNewswire

RespireRx Pharmaceuticals Inc. Appoints James Sapirstein as Executive Vice Chairman of the Board of Directors
03/01/2019
Glen Rock, N.J, Jan. 03, 2019 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a clinical stage pharmaceutical company, focused on the development of medicines that [...]
FIT Biotech Oy: FIT Biotech has received a notice from the Finland Arbitration Institute concerning the request by Bracknor Invest to initiate arbitration proceeding under the FAI rules.
03/01/2019
FIT Biotech Oy Company release 3.1.2019 at 15:30 EET FIT Biotech has received a notice from the Finland Arbitration Institute concerning the request by Bracknor Invest to initiate arbitration proceeding under the FAI [...]
FIT Biotech Oy: Changes in FIT Biotech's Board of Directors
03/01/2019
FIT Biotech Oy Company release 3.1.2019 at 15:30 EET Changes in FIT Biotech's Board of Directors Juhani Pitkäkoski has resigned because of personal reasons from FIT Biotech Oy's ("Company", FITBIO: FN Finland) Board of [...]
FIT Biotech Oy: Changes in FIT Biotech's management
03/01/2019
FIT Biotech Oy Company release 3.1.2019 at 15:30 EET Changes in FIT Biotech's management Kalevi Reijonen, FIT Biotech Oy's ("Company", FITBIO: FN Finland) Chief Medical Officer and a member of the Management Team, will [...]
Avadel Pharmaceuticals Announces Changes to Management Team and Board of Directors
03/01/2019
- Michael S. Anderson resigns as Chief Executive Officer and member of Avadel’s Board of Directors – - Gregory J. Divis, current Avadel Chief Operating Officer, named Interim Chief Executive Officer – - Geoffrey M. [...]
Cellectar Biosciences to Present at the Biotech Showcase
03/01/2019
FLORHAM PARK, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted [...]
ISS and Glass Lewis Recommend MPX Securityholders Vote in Favour of the Arrangement and MPX Shareholders Vote in Favour of the MPX Continuance and the MPX International Stock Option Plan
03/01/2019
TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (CSE: MPX) (OTC:MPXEF) (the “Company” or “MPX”) is pleased to announce that Institutional Shareholder Services Inc. (“ISS”) and Glass Lewis and Co [...]
Wildflower Opens First New York CBD Retail Store
03/01/2019
VANCOUVER, British Columbia, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Wildflower Brands Inc. (CSE: SUN) (the “Company”) is excited to announce the opening of its first Wildflower by Bridges General store in Lower Manhattan at [...]
Pluristem Concludes Positive Meeting with FDA on Development Plan for Acute Radiation Syndrome
03/01/2019
Meeting included representatives from NIH and BARDA HAIFA, Israel, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing novel [...]
Cabaletta Bio to Present at the 37th Annual J.P. Morgan Healthcare Conference
03/01/2019
RADNOR, Pa., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Cabaletta Bio Inc., a biotechnology company focused on the discovery and development of cellular therapies for B cell-mediated autoimmune diseases, today announced that [...]
Ultragenyx to Present at J.P. Morgan Healthcare Conference
03/01/2019
NOVATO, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]
Cocrystal Pharma Announces Exclusive Worldwide License and Collaboration Agreement with Merck
03/01/2019
BOTHELL, WA, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that [...]
Viveve Completes Enrollment in LIBERATE-International Trial for Improvement of Stress Urinary Incontinence
03/01/2019
ENGLEWOOD, Colo., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, announced today that it has completed enrollment in its LIBERATE- [...]
Matinas BioPharma Appoints Keith A. Kucinski, CPA, MBA as Chief Financial Officer
03/01/2019
Seasoned healthcare professional with over 20 years of strategic finance, capital markets and transactional/business-related expertise BEDMINSTER, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc [...]
United Soybean Board Awards Grant to Amfora to Increase the Protein Content of U.S. Soy
03/01/2019
Group’s focus on protein reflects effort to maintain U.S. soy farmers’ global market share SAN FRANCISCO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Amfora, a biotechnology company that is applying gene editing to sustainably [...]
Obalon Announces Promotion of Amy VandenBerg to Chief Clinical & Regulatory Affairs Officer
03/01/2019
SAN DIEGO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric [...]
Allscripts to present at the J.P. Morgan 2019 Healthcare Conference
03/01/2019
CHICAGO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) today announced that certain members of its management team will present at the J.P. Morgan 2019 Healthcare Conference in San Francisco, CA on Monday [...]
EDAP TMS SA : John Wayne Cancer Institute First US Medical Center to Acquire EDAP's Breakthrough Focal One® Technology for Prostate Tissue Ablation
03/01/2019
Focal One System Enhances Precision Tissue Ablation, Reduces Side Effects for Prostate Cancer Patients LYON, France -- January 3, 2019 - EDAP TMS SA (Nasdaq: EDAP) today announced that the John Wayne Cancer Institute ( [...]
Scholar Rock to Present at the 37th Annual J.P. Morgan Healthcare Conference
03/01/2019
CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth [...]

Pages